Literature DB >> 11147800

Identification of an interactive effect of beta3- and alpha2b-adrenoceptor gene polymorphisms on fat mass in Caucasian women.

I J Dionne1, A N Turner, A Tchernof, T I Pollin, D Avrithi, D Gray, A R Shuldiner, E T Poehlman.   

Abstract

Several adrenoceptor subtypes are expressed in adipocytes, which together exert their influence on adipocyte metabolism. Therefore, we specifically examined the interactive effect of Trp64Arg (beta3) and Glu12/Glu9 (alpha2b) adrenoceptor (AR) polymorphisms on energy metabolism and body composition in healthy women with a wide range of body habitus. We genotyped 909 unrelated women (age 55 +/- 12 [mean +/- SD] years, range 19-87; body weight 88 +/- 22 kg, range 40-167; and BMI 33 +/- 8 kg/m2, range 16-64) for Trp64Arg beta3AR and Glu12/Glu9 alpha2bAR variants. We examined the independent effect of the Glu12/Glu9 alpha2bAR variant on body composition and energy balance, in a large cohort of Caucasian women (n = 909). A second goal was to examine the interaction effect of Glu12/Glu9 alpha2bAR and Trp64Arg beta3AR on the same phenotypes. The obesity-related phenotypes studied were as follows: body weight, BMI, fat mass, visceral fat, fat-free mass, resting metabolic rate (RMR), VO2max, leisure time physical activity, and daily energy intake. Body composition and body fat distribution were measured by dual-energy X-ray absorptiometry and radiographic imagery, VO2max by a treadmill test to exhaustion, and RMR by indirect calorimetry. An analysis of covariance indicated that in the entire cohort, there was no significant difference between Glu12/Glu9 alpha2bAR carriers and control subjects for any of the obesity-related phenotypes that were examined. However, we observed a significant interaction effect of the Trp64Arg and Glu12/Glu9 variants on fat mass (P = 0.009) and percent fat (P = 0.016). Age, height, body weight, BMI, fat-free mass, visceral fat, energy expenditure, respiratory quotient, physical fitness, and energy intake were not different among groups. Collectively, these findings support an interaction effect of the two adrenoceptor variants on body fatness in Caucasian women, although the physiological mechanism by which they exert this effect remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11147800     DOI: 10.2337/diabetes.50.1.91

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

Review 1.  Genetics of diabetes.

Authors:  Richard B Horenstein; Alan R Shuldiner
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

2.  Individual Responsiveness to Exercise-Induced Fat Loss and Improvement of Metabolic Profile in Young Women is Associated with Polymorphisms of Adrenergic Receptor Genes.

Authors:  Agata Leońska-Duniec; Zbigniew Jastrzębski; Aleksandra Jażdżewska; Waldemar Moska; Ewelina Lulińska-Kuklik; Marek Sawczuk; Svetlana I Gubaydullina; Alsu T Shakirova; Pawel Cięszczyk; Adam Maszczyk; Ildus I Ahmetov
Journal:  J Sports Sci Med       Date:  2018-03-01       Impact factor: 2.988

3.  Lifestyle modifies the relationship between body composition and adrenergic receptor genetic polymorphisms, ADRB2, ADRB3 and ADRA2B: a secondary analysis of a randomized controlled trial of physical activity among postmenopausal women.

Authors:  Jennifer W Bea; Timothy G Lohman; Ellen C Cussler; Scott B Going; Patricia A Thompson
Journal:  Behav Genet       Date:  2010-04-18       Impact factor: 2.805

Review 4.  Genetics of insulin resistance.

Authors:  Maria M Mercado; John C McLenithan; Kristi D Silver; Alan R Shuldiner
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

Review 5.  Genetics of obesity: more complicated than initially thought.

Authors:  Alan R Shuldiner; Kashif M Munir
Journal:  Lipids       Date:  2003-02       Impact factor: 1.880

6.  Association between a deletion/insertion polymorphism in the alpha2B-adrenergic receptor gene and insulin secretion and Type 2 diabetes. The Finnish Diabetes Prevention Study.

Authors:  N Siitonen; J Lindström; J Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; J Tuomilehto; M Laakso; M Uusitupa
Journal:  Diabetologia       Date:  2004-07-28       Impact factor: 10.122

7.  A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults.

Authors:  April B M Grudell; Seth Sweetser; Michael Camilleri; Deborah J Eckert; Maria I Vazquez-Roque; Paula J Carlson; Duane D Burton; Autumn E Braddock; Matthew M Clark; Karen M Graszer; Sarah A Kalsy; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2008-07-16       Impact factor: 22.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.